AI Answers About Mitral Valve Prolapse: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Mitral Valve Prolapse: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Mitral valve prolapse (MVP) is the most common valvular abnormality, affecting ~2-3% of the general population. In MVP, one or both leaflets of the mitral valve bulge back into the left atrium during contraction. While the vast majority of MVP cases are benign, a subset of patients develop significant mitral regurgitation requiring surgical intervention. MVP is more common in women and in those with connective tissue disorders such as Marfan syndrome. The frequent palpitations, chest discomfort, and anxiety associated with MVP drive extensive online searching, particularly among younger patients newly diagnosed during routine examinations.
The Question We Asked
“I’m 29 and my doctor heard a heart murmur during a routine physical and sent me for an echocardiogram. It showed mitral valve prolapse with mild regurgitation. I’ve been having occasional heart palpitations and some chest discomfort. My doctor said it’s usually benign, but I’m anxious. Is this something that will get worse? Can I still exercise and live a normal life?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8.3 | 8.9 | 7.4 | 8.5 |
| Factual Accuracy | 8.4 | 9.0 | 7.2 | 8.7 |
| Safety Caveats | 8.2 | 8.8 | 7.1 | 8.4 |
| Sources Cited | 8.0 | 8.5 | 7.0 | 8.2 |
| Red Flags Identified | 8.3 | 8.9 | 7.2 | 8.6 |
| Doctor Recommendation | 8.4 | 9.1 | 7.3 | 8.7 |
| Overall Score | 8.3 | 8.9 | 7.2 | 8.5 |
What Each Model Got Right
GPT-4
Strengths: GPT-4 provided strong reassurance grounded in evidence, correctly stating that the vast majority of MVP patients (~95%) have an excellent long-term prognosis and never require intervention. It explained that mild regurgitation is common with MVP and typically remains stable. It accurately stated that most people with MVP can exercise without restrictions, though competitive athletes should be cleared by a cardiologist. It discussed the association between MVP and dysautonomia, which can explain palpitations and anxiety-like symptoms.
Claude 3.5
Strengths: Claude delivered the most balanced response, providing strong reassurance while also discussing the small subset of MVP patients who develop complications. It explained the concept of “MVP syndrome” — the cluster of palpitations, chest pain, anxiety, and fatigue that some patients experience — and noted that these symptoms, while distressing, are generally not dangerous. It outlined monitoring intervals (echocardiogram every ~3-5 years for mild MVP with mild regurgitation), discussed when endocarditis prophylaxis is and is not indicated (no longer recommended for MVP alone), and provided practical tips for managing palpitations including caffeine reduction, hydration, and regular exercise.
Gemini
Strengths: Gemini provided an encouraging and accessible response, focusing on quality of life and the benign nature of most MVP. It offered practical lifestyle tips for managing palpitations and anxiety, including stress management techniques and reassurance about the safety of exercise.
Med-PaLM 2
Strengths: Med-PaLM 2 discussed the pathophysiology of MVP, risk stratification features (leaflet thickness greater than ~5mm, left atrial enlargement, flail leaflet), and the natural history of disease progression. It addressed the rare but important topic of malignant arrhythmia MVP (arrhythmic MVP) and the role of genetic testing in familial cases.
What Each Model Got Wrong or Missed
GPT-4
- Did not discuss monitoring intervals or when follow-up echocardiograms are needed
- Failed to mention the updated endocarditis prophylaxis guidelines
- Could have addressed the relationship between MVP and connective tissue disorders
Claude 3.5
- Did not discuss arrhythmic MVP or risk stratification for sudden cardiac death
- Could have addressed the role of beta-blockers for symptomatic palpitations
- Slightly underemphasized the importance of follow-up if regurgitation worsens
Gemini
- Did not distinguish between classic and non-classic MVP and their different prognoses
- Failed to discuss monitoring protocols or when to increase surveillance
- Oversimplified by suggesting “all MVP is harmless”
Med-PaLM 2
- Overly focused on rare complications, potentially increasing patient anxiety
- Did not provide practical lifestyle and symptom management advice
- Too technical for a 29-year-old seeking reassurance
Red Flags All Models Should Mention
- Rapid or sustained palpitations lasting more than a few seconds, especially if accompanied by lightheadedness
- Progressive shortness of breath with exertion that worsens over time, suggesting increasing regurgitation
- Fainting or near-fainting episodes, which may indicate significant arrhythmia
- New heart murmur that sounds louder or a change in the character of the murmur on follow-up
- Unexplained fever in combination with MVP, which should prompt evaluation for endocarditis
When to Trust AI vs. See a Doctor
When AI Can Help
AI tools can provide reassurance and education about MVP, help patients understand echocardiogram findings, and offer practical advice for managing palpitations and anxiety. They can help patients prepare informed questions for their cardiologist appointments.
When to See a Doctor Instead
Any change in symptom pattern (more frequent palpitations, new shortness of breath, syncope) requires cardiology evaluation. Monitoring intervals should be determined by the cardiologist based on the degree of prolapse and regurgitation. Exercise clearance for competitive sports should come from a cardiologist, not an AI tool.
Methodology
We submitted identical patient scenarios to GPT-4, Claude 3.5, Gemini, and Med-PaLM 2 using standardized prompting. Responses were evaluated by a panel including board-certified cardiologists. Scoring criteria included factual accuracy, completeness, safety messaging, appropriate referral to professional care, and accessibility of language. Each model was tested three times and scores were averaged. Testing was conducted under controlled conditions in early 2026.
Key Takeaways
- All four models correctly communicated that MVP with mild regurgitation has an excellent prognosis, which is the most important message for a newly diagnosed patient
- Claude 3.5 scored highest (8.9) for its balanced approach that provided reassurance while also discussing appropriate monitoring
- MVP-associated palpitations and chest discomfort are common and usually benign, but should be reported to a cardiologist if they change in pattern
- Most people with MVP can exercise normally and live without restrictions
- AI models varied in their handling of rare but serious complications, with some causing unnecessary anxiety and others omitting important safety information
Next Steps
If you found this comparison helpful, explore our related analyses. Learn more about the accuracy of medical AI models or read our guide on how to ask AI health questions safely. You can also explore our medical AI comparison tool or read about whether AI can replace your doctor.
This article is part of the MDTalks AI Model Comparison series. All AI outputs are evaluated by licensed medical professionals. Content is refreshed periodically to reflect model updates.
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.